Arrayit Corporation Receives Contract Award From the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs

SUNNYVALE, Calif., Oct. 31, 2013 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTCBB: ARYC ), a life sciences and molecular diagnostics leader, announces today a $39,590 contract award from the United States Department of Veteran Affairs (VA). The VA Healthcare System provides some of the world's finest medicine and cutting-edge technology, as well as a teaching hospital, a full range of patient care services and research in the areas of medicine, surgery, psychiatry, rehabilitation, neurology, oncology, dentistry, geriatrics, and extended care.

The Veteran Affairs Hospital purchased the Arrayit Colorimetric Protein Microarray Platform I, which includes a microarray printer, microarray scanner, tools, kits, reagents and consumables for rapid and affordable protein microarray experimentation. Arrayit protein microarray technology empowers the Veterans Administration's mission of advanced research in geriatrics, mental health, Alzheimer's disease, spinal cord regeneration, schizophrenia, rehabilitation, HIV research, health economics, and other areas critical to our veterans.

Arrayit's tagline "Powerful Science for Life" is consistent with the VA mission statement of fulfilling President Abraham Lincoln's promise "To care for him who shall have borne the battle, and for his widow, and his orphan" by serving and honoring the men and women who are America's veterans. ARYC will fulfill the contract during the fourth quarter of this year.

About Arrayit Corporation

Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

- Powerful Science for Life

Visit http://arrayit.com/ for more information.

Safe Harbor Statement

We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended June 30, 2013.

Media Contact John Nesbett Institutional Marketing Services 203.972.9200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Historic Unity Among U.S. Latino Leaders for Mexico's Inauguration

Updated Category News Views 171

U.S. Latino leaders gathered for a historic delegation to Mexico, coinciding with the inauguration of Dra. Claudia Sheinbaum Pardo as Mexico's first female president back in 2024. This was no ordinary trip; it was a strategic move to tighten bonds between the two nations at a pivotal moment, hoping to reshape how Mexican-Americans influenced U.S. policy. Binational Ties:...

Continue Reading
Forecast for Structural Heart Devices Market Growth to USD 25B

Updated Category News Views 171

The Future of Structural Heart Devices Market Growth The structural heart devices market is on an impressive growth trajectory, projected to reach approximately USD 25 billion within the coming years. This expansion is primarily driven by the escalating demand for innovative solutions to manage various structural heart conditions. Understanding Structural Heart Devices...

Continue Reading
MediPharm Labs' Co-Founder Transitions to Board Role

Updated Category News Views 49

Significant Changes at MediPharm Labs MediPharm Labs Corp. (TSX: LABS, OTCQX: MEDIF), a leader in pharmaceutical-quality cannabis extraction and hemp-based products, has announced the departure of its President and Co-Founder, Keith Strachan, from his management role. Effective immediately, Keith will transition to the Board of Directors, where his strategic input will...

Continue Reading
Interactive Brokers Delivers Strong Performance in Q3 2024

Updated Category News Views 280

Interactive Brokers Group Reports Strong Financial Growth Interactive Brokers Group (NASDAQ: IBKR) has announced impressive financial results for the third quarter of 2024, capitalizing on a beneficent market following a U.S. interest rate cut. The company experienced significant year-over-year growth across key metrics such as client accounts, equity, and revenue....

Continue Reading
Publicis Groupe's Share Trading Update and Future Prospects

Updated Category News Views 198

Overview of Recent Share Trading Activities Publicis Groupe has recently engaged in trading its own shares as part of a program approved during its Shareholders’ Meetings. This initiative underscores the company's commitment to managing its share capital effectively, reflecting its ongoing strategy to enhance shareholder value. Transaction Details During the designated...

Continue Reading